Mustang Bio

+$0.0291 (+4.40%) Today
+$0.0093 (+1.35%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Mustang Bio and other ETFs, options, and stocks.

About MBIO

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of a broad range of proprietary chimeric antigen receptor engineered T cell (CAR T) immunotherapies and gene therapies. It develops CAR T and CRISPR/Cas9-enhanced CAR T therapies across multiple cancers, as well as lentiviral gene therapy for XSCID.

CEO
Manuel Litchman
Employees
102
Headquarters
Worcester, Massachusetts
Founded
2015

MBIO Key Statistics

Market cap
71.35M
Price-Earnings ratio
—
Dividend yield
—
Average volume
627.74K
High today
$0.6946
Low today
$0.65
Open price
$0.6867
Volume
643.45K
52 Week high
$4.06
52 Week low
$0.614

MBIO Earnings

-$0.32
-$0.21
-$0.11
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 15, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure